MITO 37

Ki67 as a predictor of response to PARP inhibitors in platinum sensitive BRCA Wild Type ovarian cancers

STATO: In attivazione
PATOLOGIA: Ovaio
CENTRO COORDINATORE MITO:
PRINCIPAL INVESTIGATOR: Giorgio Valabrega, Valentina Tuninetti
CO INVESTIGATOR: -
STUDY COORDINATOR: -

DOCUMENTAZIONE

Protocol